Sentences with phrase «patients on the drug»

Patients on the drug had a 4.9 % risk compared with an 8.7 % risk if not on the drug.

Once in treatment, the average premature termination rate was 21.9 percent, with patients on drug - only regimens 1.2 times more likely to drop out early.

But most of the time, the only way you can tell for sure is to start the patient on the drug.

For the first time, using sophisticated tools to measure skin color, blood flow, and temperature, researchers found that patients on the drug who had a very rapid onset of flushing — redness, pain, swelling, and heat to the face — rated the experience far more harshly than patients whose skin changed gradually, even to the point of extreme redness or change in temperature over time.

But if patients on the drug were only 1 percent better, the statistical significance derived from the p - value would likely have no practical value.

There was no significant difference in liver function tests between patients on drug and on placebo.

The fact that more than half the patients on my drug combination, people with serious cancer and alarming odds, had their cancer shrink is incredible.

Doesn't it make more sense for a doctor to first recommend for example curcumin or ginger, rather then immediately place their patient on a drug targeting the symptoms of psoriasis?

Skilled at counseling patients on drug treatments, provi...

• Provide Pharmacy service and support, dispensing all prescribed medications, providing health information, counseling patients on drug interaction, over the counter medications, and any client inquiries as requested.

Not exact matches

While the new mid-stage study results from DNDi were impressive (they showed cure rates of 96 % to 97 % even for the sickest patients and those with liver scarring), more late - stage trials will be necessary before the drug is available on a large scale in the developing world.

A new study published in the New England Journal of Medicine finds that Valeant Pharmaceuticals» infamous price hikes for a pair of heart drugs called nitroprusside and isoproterenol — whose prices were increased by 310 % and 720 %, respectively — had significant downstream effects on patient care.

The Silicon Valley startup's «smart pill» platform, Discover, helps doctors track patients» biometrics — and whether or not they're sticking to a drug protocol — with the help of ingestible (and on - the - body) sensors that communicate with a smartphone app.

The Food and Drug Administration (FDA) on Tuesday gave Swiss drug giant Novartis a second approval for its pioneering CAR - T cancer therapy, which uses patients» own immune cells (re-engineered outside the body and then replicated) to destroy blood cancDrug Administration (FDA) on Tuesday gave Swiss drug giant Novartis a second approval for its pioneering CAR - T cancer therapy, which uses patients» own immune cells (re-engineered outside the body and then replicated) to destroy blood cancdrug giant Novartis a second approval for its pioneering CAR - T cancer therapy, which uses patients» own immune cells (re-engineered outside the body and then replicated) to destroy blood cancers.

May 1 - Regeneron Pharmaceuticals and Sanofi will cut the net price of their expensive cholesterol drug for Express Scripts customers in exchange for greater patient access, with some savings to be shared with consumers, the companies said on Tuesday.

With a critical mass of 450,000 patients annually among them, the six centers have agreed to combine their efforts on planning clinical trials in immunotherapy, recruit patients quickly, and share the information learned — which could be the single biggest factor in speeding up drug development.

In a 564 - person trial, patients whose ovarian cancer recurred (and who had already started treatment with chemotherapy) given Rubraca, part of a new class of cancer drugs called «PARP» inhibitors, lived, on median, for double the amount of time without their disease getting even worse compared with those given a placebo.

Cancer patients, especially those on chemotherapy, can really benefit from a personal chef who knows how to make food that's especially appealing when chemotherapy drugs make food unappealing but when it is important to maintain nutrition for strength and the best health possible.

The PBMs» biggest profits no longer lie in maximizing rebates on brand - name drugs or shifting patients to higher - cost medication.

The Valeant spokeswoman wrote us that the first alcohol interaction study actually began enrolling patients and argued the drug maker is not responsible if that information is not reflected on the FDA website.

Shkreli's basic modus operandi in the biopharma sphere was to take niche drugs in treatment spaces where U.S. patients have few options (although those medicines may very well have been approved and available in other countries) and bring them to market, after which he'd maintain carte blanche on the products» prices.

But before his arrest, he said he'd use KaloBios as a vehicle to nab another niche drug, this time for treatment of the parasitic infection Chagas disease, and dramatically increase its price to the $ 60,000 to $ 100,000 range after helping it win FDA approval (the drug is approved in other countries and is provided to patients in the U.S. on a special and selective basis).

Activist hedge fund investor and recent Valeant Pharmaceuticals (vrx) board appointee Bill Ackman on Wednesday slammed the company's steep drug price hikes in testimony before the U.S. Senate Special Committee on Aging, going so far as to say the cost bumps «contributed to healthcare inflation and called into question the company's commitment to the patients it serves.»

Martin Shkreli, unaffectionately known as the «pharma bro» — and infamous for his decision to hike the list price of Daraprim, a drug used by HIV / AIDS and cancer patients to combat infections, by more than 5,000 % in 2015 under his former company Turing Pharmaceuticals — was convicted on three criminal securities fraud and conspiracy charges by a Brooklyn jury on Friday.

«The industry is preparing a thoughtful presentation of a different perspective on drug prices and the value that we bring to patients and the medical community.»

The Pittsburgh - based specialty pharmacy grew its revenue by 13,380 percent in three years to $ 42 million by focusing on the small populations of underserved patients who need orphan drugs to treat serious illnesses.

«If we bring forward innovative drugs that make a difference in the lives of patients, they'll continue to get attractive pricing,» he says, noting Biogen's work on potential breakthrough Alzheimer's and (additional) multiple sclerosis meds.

Some doctors have held off on switching patients to these drugs until there are more widely available bleeding reversal agents on the market — which may happen as soon as this year, Reuters notes.

Still, the fact that 250 Duchenne patients are willing to take a chance on the drug despite insurer pushback is a positive sign for Sarepta.

Merck says it's working with doctors to acclimate them to the diagnostic, which could prevent wasteful spending on a costly drug which may not benefit all patients.

The same outside adviser, who was unidentified in Tuesday's release, advised that a package of assistance programs to patients would: «force reporters to focus on the byzantine nature of drug pricing and health care and ensure the patient message gets out... specifically tie profits from Daraprim to the research and development of a new and more effective treatment for Daraprim patients.

The study, just published in Science, showed that the creation of what the researchers are calling microtumors can help predict drug effectiveness in cancer patients better than the current standard method of testing the drugs on rodents.

It would also provide a tighter hold on patients who require more expensive, specialty drugs — the more profitable part of the business.

Then because that emergency department doesn't know that person — they don't have a health record on that patient — they end up with a drug interaction and that creates another complication and they go back again and the cycle kind of repeats itself.»

On the heels of rival diabetes drug maker Novo Nordisk's announcement that it will limit branded drug price hikes to the single digits going forward, U.S. pharma giant Eli Lilly announced Tuesday that it is partnering with benefits manager Express Scripts and a mobile health platform hosted by Blink Health to slash patients» insulin costs.

Although the FDA can't dictate prices or reject therapies over pricing concerns (they can only focus on safety and efficacy), the agency can encourage more competition through moves like this (as well as speedier approval pathways) which could spur drug makers to produce products that ultimately lower costs for patients — a goal cited by FDA Commissioner Scott Gottlieb in announcing the list.

Drugs that worked in the microtumor worked 88 percent of the time on humans, and drugs that failed in the microtumor failed 100 percent of the time in the patDrugs that worked in the microtumor worked 88 percent of the time on humans, and drugs that failed in the microtumor failed 100 percent of the time in the patdrugs that failed in the microtumor failed 100 percent of the time in the patient.

So the focus on gut, depression, diabetes, and these other drugs was done with the U.S. patient pool in mind?

In order for companies like UniQure to make money on these novel drugs, they'll have to be priced at an exorbitant premium, which few if any patients could ever pay.

Patients on those trials had access to those drugs two years before anyone else.

Patient advocates, generic drug makers, and even some biotech investors promptly rebuked Allergan after the arrangement was announced Friday, arguing that the IP gymnastics will only worsen biopharma's miserable reputation on drug pricing issues.

The institute, which includes over 40 laboratories and more than 300 researchers, said the research would focus on modifying a patient's own immune system T - cells to target a tumor, studying ways to boost patient response to current immunotherapy drugs.

The generic drug company tripled the discount patients can receive on the cost of EpiPen to $ 300, up from the maximum $ 100 Mylan had previously offered with the use of its special «savings card.»

By printing multiple lung airways — or any other afflicted organ — from a human patient and testing drugs on them, pharma companies can bypass the ethically challenged practice of testing on animals and proceed to human clinical trials with greater confidence the drugs will actually work, according to Wadsworth.

Clinton may still have had the right idea in wanting to prevent companies from price - gouging patients on life - saving drugs.

That could have a domino effect on the other middlemen between Mylan and the patient, such as drug distributors, pharmacy benefit managers, and pharmacies, who might also have to settle for less revenue per EpiPen sale.

«The companies deliberately exploited the opportunity offered by debranding to hike up the price for a drug which is relied upon by many thousands of patients,» Philip Marsden, chairman of the CMA's case decision group, said on Wednesday.

I applaud the estimated 800 clinicians, scientists and companies working on ALS — quietly, bravely laboring away, treating patients and testing and developing drugs to halt ALS's suspected genetic origins.

Novartis took its campaign to invigorate sluggish sales of its new heart - failure medicine Entresto to a U.S. cardiologists meeting on Saturday, telling attendees that even clinically stable patients can benefit from the drug.

CVS, for example, began limiting prescriptions to seven days and prioritizing lower - dose drugs, and a number of legal complaints have been leveled against opioid manufacturers, who have been accused of using misleading marketing tactics that may have caused more patients to get hooked on potentially addicting painkillers.